Showing 1 - 10 of 142
The article tries to assess the utilization efficiency of capacity of Indian rubber industry in terms of econometric framework for the period,1979-80 to 2008-09.Capacity output has been obtained at the minimum point of short run average cost curve. The result suggests that there has been...
Persistent link: https://www.econbiz.de/10009491960
We estimate a model of drug demand and supply that incorporates insurance, advertising, and competition between branded and generic drugs within and across therapeutic classes. We use data on antiulcer drugs from 1991 to 2010. Our simulations show generics and "me-too" drugs each increased...
Persistent link: https://www.econbiz.de/10010250679
Multinational enterprises' research and development (R&D) activities are increasingly internationalised and organised into new types of network, as part of their global innovation networks. In this article, we investigate the dynamics and strategies of R&D reorganisation through an in-depth case...
Persistent link: https://www.econbiz.de/10011298030
Trade in plastic waste and scrap plays a potentially important role in helping to strengthen markets for recycled plastics as it can help to achieve economic efficiency through for instance economies of scale. But such trade has also been criticised for leading to plastic pollution when...
Persistent link: https://www.econbiz.de/10013202478
This study presents the results of a joint analysis of patterns of consumption, expenditure, and unit expenditure for a core set of drugs aimed at preventing and treating cardiovascular disease. The current study examines the relationships among three pharmaceutical variables (expenditure,...
Persistent link: https://www.econbiz.de/10012445354
This paper investigates the relationship between contract manufacturing and quality risk — a term defined as the propensity of a manufacturing plant to operate out of compliance with required procedures. Contract manufacturing plants (hereafter, CM) are increasingly being used in many...
Persistent link: https://www.econbiz.de/10011574360
We examine six molecules facing initial loss of US exclusivity (LOE, from patent expiration or challenges) between June 2009 and May 2013 that were among the 50 most prescribed molecules in May 2013. We examine prices per day of therapy (from the perspective of average revenue received by retail...
Persistent link: https://www.econbiz.de/10010969367
The contribution of this paper is twofold. First, it presents the results of a “history-friendly” simulation model of evolution of the pharmaceutical industry. Second, it aims at contributing to a more general methodological discussion about agent-based models by proposing an econometric...
Persistent link: https://www.econbiz.de/10010907946
Historical accounts suggest that Jewish ?migr?s from Nazi Germany revolutionized US science. To analyze the ?migr?s' effects on chemical innovation in the United States, we compare changes in patenting by US inventors in research fields of ?migr?s with fields of other German chemists. Patenting...
Persistent link: https://www.econbiz.de/10010949130
We use the unique regulatory environment of the pharmaceutical industry to examine how potential competition affects generic drug pricing. Our identification strategy exploits a provision of the Hatch-Waxman Act that awards 180 days of marketing exclusivity to the first valid generic drug...
Persistent link: https://www.econbiz.de/10011009864